COMPETITIVE-INHIBITION OF ZIDOVUDINE CLEARANCE BY PROBENECID DURING CONTINUOUS COADMINISTRATION

被引:21
作者
WONG, SL [1 ]
HEDAYA, MA [1 ]
SAWCHUK, RJ [1 ]
机构
[1] UNIV MINNESOTA,COLL PHARM,DEPT PHARMACEUT,MINNEAPOLIS,MN 55455
关键词
ZIDOVUDINE; PROBENECID; COMPETITIVE INHIBITION; PHARMACOKINETICS;
D O I
10.1023/A:1018993524818
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The pharmacokinetics of zidovudine in the rabbit were studied during coadministration of probenecid at two infusion rates. Each animal (n = 6) served as its own control during an initial 8-hr infusion of zidovudine. In the second 8-hr infusion period, probenecid was coadministered with zidovudine. Urine samples were collected by bladder flush hourly for 19 hr. Plasma samples were taken at the midpoint of the urine collection interval and at predetermined intervals for 3 hr postinfusion. Plasma concentrations of zidovudine reached steady state during control periods but showed incomplete attainment of steady state during the infusions of probenecid at the higher rate. Total and renal clearance of zidovudine were reduced by 24.0 +/- 4.0 and 20.7 +/- 15%, respectively, during low-dose probenecid treatment and 48.9 +/- 7.4 and 55.7 +/- 3.4%, respectively, with high-dose probenecid treatment. Plasma probenecid concentrations during low-dose and high-dose infusion were 56.9 +/- 12 and 248 +/- 42-mu-g/ml. Postinfusion data showed that the zidovudine terminal half-life during high-dose probenecid treatment was longer than that with low-dose probenecid treatment (58.2 +/- 4.6 vs 39.0 +/-9.1 min). The volume of distribution of zidovudine also decreased (1.76 +/- 0.27 vs 1.10 +/- 0.095 L/kg) as a result of probenecid coadministration. The results are consistent with competitive inhibition of renal and nonrenal clearances. A drug interaction model relating zidovudine clearances to plasma probenecid concentrations was derived. Michaelis-type constants for probenecid inhibition of zidovudine renal and nonrenal clearances were 73 and 55-mu-g/ml, respectively. The maximum proportion of AZT's renal clearance subject to inhibition is significantly greater (72%) than that of the nonrenal clearance (54%) and agrees closely with the fraction not filtered.
引用
收藏
页码:228 / 235
页数:8
相关论文
共 26 条
  • [21] MUDGE GH, 1985, PHARMACOL BASIS THER, P929
  • [22] RUNKEL R, 1978, CLIN PHARMACOL THER, V24, P706
  • [23] PHARMACOKINETICS OF PROBENECID FOLLOWING ORAL DOSES TO HUMAN VOLUNTEERS
    SELEN, A
    AMIDON, GL
    WELLING, PG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (11) : 1238 - 1242
  • [24] EFFECT OF PROBENECID ON THE FORMATION AND ELIMINATION OF ACYL GLUCURONIDES - STUDIES WITH ZOMEPIRAC
    SMITH, PC
    LANGENDIJK, PNJ
    BOSSO, JA
    BENET, LZ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) : 121 - 127
  • [25] EFFECTS OF PROBENECID ON KETOPROFEN KINETICS
    UPTON, RA
    WILLIAMS, RL
    BUSKIN, JN
    JONES, RM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) : 705 - 712
  • [26] PHARMACOKINETICS OF PROPYLENE-GLYCOL IN THE RABBIT
    YU, DK
    SAWCHUK, RJ
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1987, 15 (05): : 453 - 471